Infectious diseases pose a significant and persistent threat to the U.S. Army force protection and readiness. While
the primary mission of Army medical research is protection of the force and their family members, vaccines and treatments developed by Army researchers also benefit global public health.
Army medicine is a leader in global efforts against the world’s most pervasive and deadly infectious diseases, such as malaria, HIV/AIDS, Ebola and dengue. At the Walter Reed Army Institute of Research, infectious disease physicians and scientists work alongside civilian researchers and medical professionals, testing and developing products that will reduce the impact of some of the world’s most lethal diseases.
Today’s youth have a chance to play a role in this vital work. Those who pursue careers and opportunities in Army medicine have the chance to contribute to cutting-edge research that will have a lasting health impact on the world.
Examples of the Walter Reed Army Institute of Research’s contributions to global health over the years include:
- Leading the trial of the first HIV/AIDS vaccine, to demonstrate protection against infection.
- Developing some of the most widely used anti-malarial drugs, including chloroquine, primaquine, doxycycline and atovaquone/proguanil.
- Advancing major steps forward in the scientific advancement of a first-ever malaria vaccine and taking part in Phase III testing overseas (with GlaxoSmithKline).
- Helping develop vaccines to prevent meningitis, Japanese encephalitis, hepatitis A, adenovirus and influenza.
In efforts to address current public health threats, the Department of Defense (DoD) is monitoring mosquitoes in 27 states for the Zika virus.
To learn more about Army medicine’s contributions to global public health and how you can get involved, please visit http://www.goarmy.com/amedd.html